Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1/2 2Phase 1 2Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1Colonic Neoplasms 1

Interventions

Oxaliplatin 7Fluorouracil 6Leucovorin 5Bevacizumab 4Watchful Waiting 3Capecitabine 3XELOX 2Neoadjuvant Therapy 2Irinotecan 2Indocyanine Green 2Chemotherapy, Adjuvant 2Cetuximab 2sulindac sulfone 1pembrolizumab 1encorafenib 1dehydroftorafur 1cyclopropapyrroloindole 1Tranexamic Acid 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Panitumumab 1Observation 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Iohexol 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × dehydroftorafur × Clear all
NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

NRG Oncology

Phase 2/3 Active not recruiting
635 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡